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The psoriasis susceptibility locus 1 (PSORS1) mutation is assumed to reside within a region around human
leukocyte antigen-C spanning 250 kb, termed risk haplotype (RH) 1/2. By re-analyzing a published data set with a
previously developed method, the haplotype sharing statistic, we conﬁrm localization of PSORS1 to the RH1 region
and reﬁne its location to marker M6S168. We replicate this result in an independent patient sample. The target
region harbors fragments of a human endogenous retrovirus K (HERV-K) endogenous retrovirus. Two single-
nucleotide polymorphisms with alleles differing between high- and low-risk haplotypes are located within the
HERV-K dUTPase. One of these encodes a predicted non-conserved Glu–Arg exchange. The HERV-K dUTPase is
expressed in peripheral blood and in normal as well as lesional psoriatic skin. Our results indicate that an en-
dogenous retroviral dUTPase constitutes a candidate gene for the PSORS1 mutation.
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The allele causing strong association of psoriasis with the
so-called PSORS1 locus at human leukocyte antigen (HLA)-
C is still elusive (reviewed in Elder et al, 2001; Capon et al,
2002). Nair et al (2000) identified an approximately 250 kb
spanning interval (designated risk haplotype (RH)1/RH2)
based on transmission disequilibrium text (TDT) analysis
of founding haplotypes in a large type 1 psoriasis cohort.
This interval contains three pseudogenes (HCGII-2, HCGIX-
3, and NOB4, all on acc. Nr. AP000508), as well as
two genes, corneodesmosin (NM__001264) and HCR
(AF216493), with a putative role in the skin. The latter have
both been proposed as PSORS1 candidate genes (Schmitt-
Egenolf et al, 2001; Asumalahti et al, 2002).
We re-analyzed the haplotype data published by (Nair
et al, 2000) using a previously developed haplotype sharing
statistic termed HSS. We used the published transmission
and non-transmission frequencies to assemble patient and
control haplotype sets as detailed in the online supplement
(Methods) and compared these sets for haplotype sharing
using the HSS method. As shown in Fig 1A, excess haplo-
type sharing among patient haplotypes peaks strikingly at
marker M6S168. The log10 p-value at this marker of 11.9
corresponds to a corrected p-value of 1.7  1011; how-
ever, excess haplotype sharing as such is detectable over
most of the entire 1.1 Mb interval plotted. On the basis of
haplotype sharing excess, we also performed a so-called
HSS directional test (Fig 1B). This test further defines the
interval likely to contain a disease-causing mutation at a
marker exhibiting maximal excess haplotype sharing (see
online Methods section). A clear decrease in excess haplo-
type sharing among patients is visible to the right of
M6S105 in the telomeric direction and to the left of M6S172
in the centromeric direction. The curves intersect in
the 6.4 kb interval bordered by M6S168 and M6S178.
Taken together, these results confirm the localization of
the PSORS1 mutation within the RH1/RH2 interval (dashed
black line in Fig 1A) by an independent statistical method
and suggest a more refined localization between markers
M6S168 and M6S178. We also verified this mapping result
in a novel patient sample (see online supplementary Fig S1).
Thus, HSS analysis of the new patient sample and the data
set from Nair et al (2000) both suggest that the interval
around M6S168 (between M6S105 and M6S178) may har-
bor a disease-predisposing sequence variant.
A BLAST search of this region revealed residual frag-
ments of a human endogenous retrovirus K (HERV-K) family
endogenous retrovirus, exhibiting the highest homology to
the tandem-repeat virus HML-2.Hom on chromosome 7
(see online Fig S2). Two open reading frames (ORF), des-
ignated ORF22576 and ORF23048 based on their position
on reference clone AC006048, represent segments of the
C-terminal HERV-K Gag gene and the N-terminal Pro gene
of the HERV-K genome, respectively. No HERV-K LTR seg-
ments are retained in the PSORS1 region. Focussing on the
target region between 21 and 25 kb on clone AC006048
containing the two ORF, we identified sequence variations
related to psoriasis risk status by comparing high- and
Abbreviations: HERV-K, human endogenous retrovirus-K; HSS, ha-
plotype sharing statistic; RH, risk haplotype; SNP, single-nucleotide
polymorphism
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low-risk haplotype DNA pools (outlined in online supple-
mentary Table S2). Of 17 nucleotide variations identified
within a 4.2 kb segment, four are located within ORF23048
(data not shown). Sequencing a 400 bp segment containing
these variations in an extended patient sample revealed that
only two of the four variations between the high risk (HR)
and low risk (LR) pools correspond to single-nucleotide po-
lymorphism (SNP) (data not shown). One additional SNP is
located in the potential 30 untranslated region of ORF23048.
These SNP were designated SNP143, SNP200, and
SNP315 based on their position in the sequenced 400 bp
segment. Their frequencies are detailed in online supple-
mentary Table S3. All 10 individuals in the HR pool were
homozygous for the psoriasis-associated haplotype C-A-G
at SNP143/200/315, whereas all LR pool individuals were
homozygous for the opposite haplotype (not shown).
ORF23048, which contains two of the three identified
SNP, represents a fragment of the N-terminal HERV-K pro-
tease gene. In the intact retrovirus, this fragment is pro-
teolytically processed, forming the retroviral dUTPase
(online supplementary Fig S3). HERV-K dUTPases contain
five evolutionary conserved motifs (Harris et al, 1997), of
which the most C-terminal motif is least conserved. The
amino acid sequence homology between ORF23048 and
the HERV-K dUTPase breaks off, after Y182 before motif 5,
as a result of a frameshift, whereas homology extends
through nt24274 on the nucleotide level (data not shown).
The predicted amino acid variations between the HR and LR
pools (G184 ! R; R187 ! K) immediately follow the break
in sequence homology. The R187 ! K substitution corre-
sponds to SNP143 (G ! A), the A allele being associated
with psoriasis. Based on the primary sequence, it is not
possible to predict whether one or both of the PSORS1
dUTPase variants could be enzymatically active.
We next performed RT-PCR expression analysis dUT-
Pase ORF from whole blood employing primer pair 7 (online
methods, Appendix B), previously shown to be specific in
the PSORS1 sequencing experiment. As shown in Fig 2A,
we observed the expression of the dUTPase ORF in pe-
ripheral blood from three of four patients tested and all five
healthy volunteers. The PSORS1 dUTPase transcript was
also detectable in polyAþ RNA prepared from peripheral
blood mononuclear cell (PBMC) of a healthy volunteer (Fig
2B). The identity of all PCR products was verified by se-
quencing (online Fig S4 and data not shown). The BLAST
alignment of the sequenced RT-PCR product supplied in
online supplementary Fig S4 demonstrates that the ampli-
fied transcript unequivocally derives from the PSORS1 lo-
Figure 1
Haplotype-sharing statistic (HSS) re-analysis of haplotype clusters
from Nair et al (2000). The x-axis shows markers from (Nair et al, 2000)
telomere to centromere, beginning at marker D6S273. (A) HSS analysis,
quantifying excess in mean haplotype length shared among patient
haplotypes around each marker as compared with that among control
haplotypes. The horizontal dashed lines represent PSORS1, the risk
haplotype (RH)1/RH2 risk interval, respectively. (B) Directional analysis
quantifying excess in mean haplotype length shared among patients as
compared with controls only telomeric (solid line) or only centromeric
(dashed line) from each marker. The arrowhead marking the intersec-
tion of both curves indicates the most likely interval harboring the
PSORS1 mutation.
Figure2
Expression of the human endogenous retrovirus K (HERVK) dUT-
Pase at the PSORS1 locus. (A) Peripheal blood from psoriasis patients
(upper panel) or healthy donors (lower panel). RT-PCR was performed
from total RNA with primers specific for the dUTPase open reading
frame (ORF) or b-actin. ‘‘þ ’’ and ‘‘’’ indicate cDNA synthesis per-
formed in the presence or absence of reverse transcriptase, respec-
tively. The expected size of the PSORS1 dUTPase band is 430 bp and
that of b-actin is 466 bp. (B) Detection of the PSORS1 dUTPase in
polyAþ RNA from peripheral blood mononuclear cells from a healthy
donor, performed as in (A). (C) Detection of the dUTPase ORF at
PSORS1 in skin by nested RT-PCR as detailed in online methods from
two independent psoriatic plaque samples (pso L 1.2), non-lesional
skin, and skin from a healthy proband (con skin). The expected size of
the nested RT-PCR PSORS1 dUTPase product is 260 bp.
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cus based on the perfect match only to the PSORS1-con-
taining clones. The SNP143 T allele was present in the three
psoriatic blood samples and three of the five healthy con-
trols expressed the SNP143 C allele. One sample ex-
pressed both alleles. Finally, we examined expression of the
PSORS1 dUTPase in skin. As shown in Fig 2C, the dUTPase
expression was detectable in healthy skin, as well as in one
non-lesional and two lesional psoriasis skin samples, albeit
only by nested PCR. Again, the derivation of all PCR prod-
ucts was verified by sequencing and BLAST analysis. The
psoriasis-associated SNP143 C allele was found in one of
the two lesional skin samples and one of the two PBMC
samples. Taken together, these data indicate that the HERV-
K dUTPase from the PSORS1 locus is commonly expressed
in peripheral blood and is also detectable in skin.
These data confirm localization of PSORS1 to the RH1/
RH2 region defined by Nair et al (2000) and suggest its fine
mapping in the intervals around marker M6S168. A recent
study on genetic association of psoriatic arthritis in a Span-
ish association also defines an interval including HLA-C and
M6S168, but excluding markers in the HCR gene (Martinez-
Borra et al, 2003). That study independently confirms the
PSORS1 interval suggested by our data. We suggest that
HSS analysis be applied to existing SNP data sets in an
effort to further confirm the current fine mapping of the
PSORS1 location.
We identified a dUTPase derived from a defunct HERV-K
endogenous retrovirus in the PSORS1 target interval. Align-
ment of the predicted protein sequence with other HERV-K
dUTPases (online Fig S3) shows that the last of five con-
served motifs has been lost from the PSORS1 dUTPase.
Therefore, it is uncertain whether the predicted protein is
enzymatically active; however, because viral, as opposed to
host, dUTPases are active in the cytosol, even low additional
PSORS1-derived dUTPase activity may contribute to viral
persistence or replication in cell types not otherwise
susceptible (Fleischmann et al, 2002). Alternatively, an
enzymatically non-functional PSORS1 dUTPase may contrib-
ute to psoriasis pathogenesis as a dominant-negative protein
or auto-antigen. Independent of the dUTPase, a PSORS1
mutation located at M6S168 may exert positional effects on
nearby genes.
Finally, our results suggest that expression of the
PSORS1 retroviral dUTPase in PBMC is a common phe-
nomenon. It will be most informative to test whether the
recently described highly prevalent systemic IgG response
against endogenous retroviruses in psoriasis patients
(Moles et al, 2003) includes antibodies against the HERV-
K dUTPase fragment described in this report.
All studies involving human samples were approved by
the Charite´ ethics review board. This study was conducted
according to Declaration of Helsinki principles. All partici-
pants gave written informed consent prior to enrollment.
Supplementary Material
The following material is available from http://www.blackwellpublishing.
com/products/journals/suppmat/JID/JID23504/JID23504sm.htm
Figure S1
The Haplotype Sharing Statistic(HSS) computed in the novel
German patient sample for the PSORS1 target region. Values on
the x-axis represent markers described by (Nair et al. 2000) from telo-
mere to centromere beginning with marker M6S101. (A) HSS analysis
for all patients (solid line) and type 1 psoriasis patients (dashed
line). Significant excess in haplotype sharing is detectable among all
patients, as well as among type 1 psoriasis patients, when compared to
the control haplotypes, peaking at marker M6S105 with a maximal
log10 p – value of 9.9. Excess in haplotype sharing was greater in the
entire patient sample than in the type 1 psoriasis subgroup, suggesting
that the genetic association of the non-type 1 subgroup with the
PSORS1 locus, albeit weaker, has an additive effect within the un-
stratified sample in this type of analysis. (B) HSS directional test of
excess mean haplotype sharing only telomeric (dashed line) or only
centromeric (solid line) from each marker. Excess haplotype sharing
declines to the left of marker M6S105 in the telomeric direction and to
the right of marker M6S178 in the centromeric direction, both curves
intersecting at marker M6S168. Figure 3C, D Directional HSS analysis
performed under inclusion of marker M6S167, here plotted separately
since this marker was not formally in Hardy Weinberg equilibrium. Upon
inclusion of this marker, excess in haplotype sharing peaks even more
clearly centered at marker M6S168.
Figure S2
Retroviral elements telomeric of HLA-C are residual fragments of
an HERV-K retrovirus. (A) Cartoon illustrating the physical genomic
location of the PSORS1 target region between markers 9 and 13
(M6S167-M6S102). The box marks the position of a 3.3 kb EcoR1
restriction fragment described by (Mizuki et al, 1997). The shaded
bars mark the only ORFs exhibiting homology to GenBank sequences;
the dashed line indicates a ‘‘repeat’’ region of high sequence homo-
logy to numerous genomic sequences. ORF22576 and ORF23048
were predicted by ORFinder analysis (www.ncbi.nlm.nih.gov) analysis
of genomic clone AC006048. (B) Schematic alignment of the PSORS1
region contained on clone AC006048 with the most similar HERV
sequence on chromosome 7 (HML-2.Hom, accession number AF074086).
Sequences were aligned using Pairwise BLAST.
Figure S3
Sequence alignment of the predicted amino acid sequence
encoded by ORF23048 in the PSORS1 region, as determined for
the high risk (HR) and low risk (LR) pools, respectively, with known
dUTPases, as follows: HERV-K chr.7¼HML-2.Hom (GenBank ac-
cession number AF074086), HERV-K cons.¼dUTPase consensus
sequence as proposed by (Harris et al, 1997); FIV¼dUTPase from
feline immunedeficiency virus (SwissProt acc. nr. P16088); MMTV¼
dUTPase from mouse mammary tumor virus (SwissProt P10271),
E. coli (SwissProt Q8XDA1), human¼mitochondrial isoform of the
human dUTPase (P33316). Alignment is only shown for the region
encompassing evolutionary conserved structural motifs (Harris
et al, 1999), shown as boxes. Shaded residues denote amino
acids identical to, or conservative replacements of the HERV-K
dUTPase consensus sequence. The location of the dUTPase
N-Terminus after proteolytic cleavage of the polyprotein precurser is
not known.
Figure S4
BLAST alignment of a sequenced RT-PCR product generated from
peripheral blood-derived cDNA from a healthy proband using
primer pair 7 (see Appendix B). The Query sequence is shown in red,
genomic clones derived from the PSORS1 target region at Chr. 6p21
are shown in blue; genomic clones derived from other chromosomal
sites are shown in black. The location of the SNPs detailed in
online table 4 is underlined, with the SNP allele printed in green.
Reference clone AC006048 is set in bold type. The alignment shows
that only the clones derived from the PSORS1 site exhibit a perfect
match to the PCR product, demonstrating its derivation from this
genomic locus.
Table S1. Patient sample
Table S2. Haplotypes used to detect sequence variants associated
with psoriasis risk status
Table S3. Allele distribution at SNPs located within ORF23048
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